Crossmark

Development and validation of a nomogram combining PI-RADS v2.1 and clinical indicators for the diagnosis of prostate cancer in patients with PSA ≤ 20 ng/mL

Crossref DOI link: https://doi.org/10.1007/s00261-025-05231-0

Published Online: 2025-10-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Su, Zhilian

Cai, Bufeng

Li, Luyao

Huang, Zhaohai

Fu, Yuchuan
Funding

Funding for this research was provided by:

The Pingyang Science and Technology program (Y2024A01, Y2024A01)
License Information

Text and Data Mining valid from 2025-10-13

Version of Record valid from 2025-10-13
More Information

Article History

Received: 18 February 2025

Revised: 26 May 2025

Accepted: 24 September 2025

First Online: 13 October 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below